Selective modulation of inducible nitric oxide synthase isozyme in myocardial infarction

被引:72
|
作者
Wildhirt, SM [1 ]
Suzuki, H [1 ]
Horstman, D [1 ]
Weismuller, S [1 ]
Dudek, RR [1 ]
Akiyama, K [1 ]
Reichart, B [1 ]
机构
[1] HUNTINGTON MED RES INST, DEPT EXPT CARDIOL, PASADENA, CA USA
关键词
myocardial infarction; regional blood flow; hemodynamics; ischemia;
D O I
10.1161/01.CIR.96.5.1616
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Inducible nitric oxide synthase (iNOS) is activated in cardiac disorders, We investigated the contribution of increased iNOS activity to the development of left ventricular dysfunction after myocardial infarction by selective inhibition of the isozyme. Methods and Results Male New Zealand rabbits were subjected to myocardial infarction, Animals were treated with either saline, S-methylisothiourea sulfate (SMT) (a selective iNOS inhibitor), or N-omega-nitro-L-arginine (L-NNA) (a nonselective NOS inhibitor). Inducible and constitutive NOS (cNOS) activity, plasma NOx, cGMP, hemodynamics, and myocardial blood flow were measured before and 5: 24, and 72 hours after coronary occlusion. Infarction 72 hours after occlusion resulted In increased myocardial iNOS activity, increased cardiac NOx production, and elevated cGMP levels. cNOS remained unchanged. Infarction increased left ventricular end-diastolic pressure (LVEDP) and decreased maximum +dP/dt and -dP/dt. L-NNA inhibited iNOS and cNOS activities and plasma NOx levels. L-NNA further increased LVEDP and reduced myocardial blood flow. Administration of SMT 72, hours after infarction significantly inhibited iNOS and cardiac NOx production but had no effects on cNOS. SMT improved left ventricular maximum +dP/dt and -dP/dt and decreased LVEDP. Myocardial blood flow in the remote myocardium increased. Conclusions These findings suggest that induction of iNOS activity 72 hours after infarction exerts negative inotropic effects and contributes to the development of myocardial dysfunction! selective modulation of increased iNOS activity by SMT improves cardiac performance, enhances myocardial blood flow, and may be beneficial in the treatment of acute myocardial infarction.
引用
收藏
页码:1616 / 1623
页数:8
相关论文
共 50 条
  • [31] Inducible nitric oxide synthase gene therapy with a new generation adenovirus protects against myocardial infarction in vivo
    Li, QH
    Guo, YR
    Lowenstein, C
    Stevenson, S
    Wu, WJ
    Liao, LF
    Xuan, YT
    Bolli, R
    CIRCULATION, 2001, 104 (17) : 228 - 228
  • [32] Role of inducible nitric oxide synthase in cardiac function and remodeling in mice with heart failure due to myocardial infarction
    Liu, YH
    Carretero, OA
    Cingolani, OH
    Liao, TD
    Sun, Y
    Xu, J
    Li, LY
    Pagano, PJ
    Yang, JJ
    Yang, XP
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2005, 289 (06): : H2616 - H2623
  • [33] Enhanced ß-adrenergic response in rat papillary muscle by inhibition of inducible nitric oxide synthase after myocardial infarction
    Pinto, V. D.
    Cutini, G. S.
    Sartorio, C. L.
    Paigel, A. S.
    Vassallo, D. V.
    Stefanon, I.
    ACTA PHYSIOLOGICA, 2007, 190 (02) : 111 - 117
  • [34] Dual Role of Inducible Nitric Oxide Synthase in Left Ventricular Injury and Protection after Myocardial Infarction in Mice
    Shimazu, Takayuki
    Otani, Hajime
    Yoshioka, Kei
    Okazaki, Toru
    Fujita, Masanori
    Iwasaka, Toshiji
    CIRCULATION, 2010, 122 (21)
  • [35] SELECTIVE-INHIBITION OF INDUCIBLE NITRIC-OXIDE SYNTHASE BY AGMATINE
    AUGUET, M
    VIOSSAT, I
    MARIN, JG
    CHABRIER, PE
    JAPANESE JOURNAL OF PHARMACOLOGY, 1995, 69 (03): : 285 - 287
  • [36] NOVEL POTENT AND SELECTIVE INHIBITORS OF INDUCIBLE NITRIC-OXIDE SYNTHASE
    NAKANE, M
    KLINGHOFER, V
    KUK, JE
    DONNELLY, JL
    BUDZIK, GP
    POLLOCK, JS
    BASHA, F
    CARTER, GW
    MOLECULAR PHARMACOLOGY, 1995, 47 (04) : 831 - 834
  • [37] SELECTIVE-INHIBITION OF THE INDUCIBLE NITRIC-OXIDE SYNTHASE BY AMINOGUANIDINE
    MISKO, TP
    MOORE, WM
    KASTEN, TP
    NICKOLS, GA
    CORBETT, JA
    TILTON, RG
    MCDANIEL, ML
    WILLIAMSON, JR
    CURRIE, MG
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 233 (01) : 119 - 125
  • [38] Selective heterocyclic amidine inhibitors of human inducible nitric oxide synthase
    Moormann, AE
    Metz, S
    Toth, MV
    Moore, WM
    Jerome, G
    Kornmeier, C
    Manning, P
    Hansen, DW
    Pitzele, BS
    Webber, RK
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (19) : 2651 - 2653
  • [39] Selective expression of inducible nitric oxide synthase in human prostate carcinoma
    Klotz, T
    Bloch, W
    Volberg, C
    Engelmann, U
    Addicks, K
    CANCER, 1998, 82 (10) : 1897 - 1903
  • [40] U-19451A: A selective inducible nitric oxide synthase inhibitor
    Stratman, NC
    Fici, GJ
    Sethy, VH
    LIFE SCIENCES, 1996, 59 (11) : 945 - 951